Provexis PLC
04 May 2007
4 May 2007
PROVEXIS PLC ('Provexis' or the 'Company')
Directorate Change
Provexis plc (ticker PXS.L), the nutraceutical company that develops
scientifically-proven functional and medical foods, has appointed Jonathan Brett
Diggines to its Board as a non-executive director with immediate effect.
Jonathan Diggines, 54, is Chief Executive Officer of Enterprise Ventures Group
Limited, a 19.4 per cent shareholder in the Company. Jonathan, who is a
solicitor, joined Enterprise Ventures in 2005 and had previously spent 10 years
as Managing Director of Murray Johnstone Private Equity where he managed
substantial private equity and venture funds. Jonathan holds or has held the
following directorships or been a partner in the following partnerships within
the five years prior to this announcement:
• Enterprise Ventures (General Partner Coalfields) Limited
• Enterprise Ventures (General Partner EVF/LEV) Limited
• Enterprise Ventures (General Partner HSBC European Fund) Limited
• Enterprise Ventures (General Partner HSBC UK Enterprise Fund) Limited
• Enterprise Ventures (General Partner Rising Stars) Limited
• Enterprise Ventures (General Partner Rising Stars II) Limited
• Enterprise Ventures Limited
• Enterprise Ventures Group Limited
• Enterprise Ventures Nominees Limited
• LE Founders Limited
• LE Founders II Limited
• LE Founders III Limited
• Nichols plc
• North West Enterprise Investment Limited
• Rising Stars Growth Fund Limited
• Carbutt & Co. (1928) Limited
• LE Founders Limited
• MJPAP (Syndications) Limited
• MJPAP II (Syndications) Limited
• T F Willow Limited
• Weigh A Way Limited
• W F P Willow Limited
• W G Willow Limited
• W I Willow Limited
• W Willow Limited
• British Venture Capital Association
• RAL (S&G) Limited
• Sumit Venture Fund One Limited
• STF Management Limited
• SEV Investments Limited
• SEV Holdings Limited
• BIG (General Partner) Limited
• Regent Street Ventures Limited
• Aberdeen Murray Johnstone Private Equity Limited
• Euractions Management Limited
• Murray Johnstone Limited
• Callform Limited
• Aberdeen Growth Opportunities VCT PLC
• M J Founders Limited
• COIP (GB) Limited
• Aberdeen Asset Managers Limited
• AMJPEF Founder Partner Limited
• AMJPEF GP Limited
There are no further disclosures to be made in accordance with Schedule 2(g) of
the AIM Rules.
Dawson Buck, Chairman of Provexis said: 'I am delighted that Jonathan Diggines
has joined the Board of Provexis. He brings a considerable wealth of experience
gained from his management of venture funds and from his portfolio of
non-executive director roles both in public and private companies, including a
number of significant food and drink sector investments. These attributes
combined with his standing in the private equity and venture capital industry
will add significant value to the strategic development of our proprietary
technologies.'
- ENDS -
Enquiries:
Provexis Plc
Stephen Moon, Chief Executive Officer 020 8392 6634
Arbuthnot Securities
Tom Griffiths
Alasdair Younie 020 7012 2000
Adventis Financial PR
Chris Steele 020 7034 4759
Annie Evangeli 020 7034 4757
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.